Arthrosi Therapeutics
Pre-clinicalArthrosi Therapeutics develops small molecule therapies for gout and other inflammatory diseases.
Founded
2018
Focus
Small Molecules
About
Arthrosi Therapeutics develops small molecule therapies for gout and other inflammatory diseases.
Funding History
2Total raised: $60M
Series B$40MUndisclosedDec 15, 2021
Series A$20MUndisclosedAug 15, 2019
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile